Evidence map›Paper›PMID 32226773›Full record

ReviewFrontiers in oncology2020

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma.

Dirk Van Gestel, Tatiana Dragan, Vincent Grégoire, Mererid Evans, Volker Budach

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Indicators to evaluate quality of care in head and neck cancer in Spain.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Dirk Van GestelDepartment of Radiation Oncology Head and Neck Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Tatiana DraganDepartment of Radiation Oncology Head and Neck Unit, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Vincent GrégoireRadiation Oncology Departement, Léon Bérard Cancer Center, Lyon, France.
Mererid EvansDepartment of Clinical Oncology, Velindre University NHS Trust, Cardiff, United Kingdom.
Volker BudachDepartments of Radiation Oncology, Charité University Medicine Berlin, Berlin, Germany.
Centre de Recherche en Cancérologie de Lyon · FRCharité - Universitätsmedizin Berlin · DEInstitut Jules Bordet · BEUniversité Libre de Bruxelles · BEVelindre NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of radiotherapy (RT) quality assurance (QA) has been demonstrated by numerous studies and is particularly important for head and neck cancer (HNC) treatment due to the complexity of RT target volumes in this region and the multiple adjacent organs at risk. The RT planning process includes many critical steps including interpretation of diagnostic imaging, image fusion, target volume delineation (tumor, lymph nodes, and organs at risk), and planning. Each step has become highly complex, and precise and rigorous QA throughout the planning process is essential. The ultimate aim is to precisely deliver radiation dose to the target, maximizing the tumor dose and minimizing the dose to surrounding organs at risk, in order to improve the therapeutic index. It is imperative that RT QA programs should systematically control all aspects of the RT planning pathway and include regular end-to-end tests and external audits. However, comprehensive QA should not be limited to RT and should, where possible, also be implemented for surgery, systemic therapy, pathology, as well as other aspects involved in the interdisciplinary treatment of HNC.

Indexed as

best practicehead and neck cancerIMRTquality assuranceradiotherapysquamous cell carcinoma

Identifiers

PMID32226773
PMCPMC7081058
OpenAlexW3012081937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.